Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity

J R Soc Interface. 2013 Jul 3;10(86):20130414. doi: 10.1098/rsif.2013.0414. Print 2013 Sep 6.

Abstract

Dengue, a mosquito-borne virus of humans, infects over 50 million people annually. Infection with any of the four dengue serotypes induces protective immunity to that serotype, but does not confer long-term protection against infection by other serotypes. The immunological interactions between serotypes are of central importance in understanding epidemiological dynamics and anticipating the impact of dengue vaccines. We analysed a 38-year time series with 12 197 serotyped dengue infections from a hospital in Bangkok, Thailand. Using novel mechanistic models to represent different hypothesized immune interactions between serotypes, we found strong evidence that infection with dengue provides substantial short-term cross-protection against other serotypes (approx. 1-3 years). This is the first quantitative evidence that short-term cross-protection exists since human experimental infection studies performed in the 1950s. These findings will impact strategies for designing dengue vaccine studies, future multi-strain modelling efforts, and our understanding of evolutionary pressures in multi-strain disease systems.

Keywords: cross-protection; dengue; infectious disease modelling; time-series models.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Cross Protection*
  • Cross Reactions / immunology
  • Culicidae / virology
  • Dengue Virus / immunology*
  • Dengue* / epidemiology
  • Dengue* / genetics
  • Dengue* / virology
  • Female
  • Humans
  • Immunologic Memory*
  • Male
  • Models, Immunological*
  • Retrospective Studies
  • Thailand / epidemiology